Biotechnological potential of sponge-associated bacteria. 2014

Juliana F Santos-Gandelman, and Marcia Giambiagi-deMarval, and Walter M R Oelemann, and Marinella S Laport

As sessile and filter-feeding metazoans, marine sponges represent an ecologically important and highly diverse component of marine benthic communities throughout the world. It has been suggested that marine sponges are hosts to many microorganisms which can constitute up to 40-60% of its biomass. Recently, sponges have attracted a high interest from scientific community because two important factors. First there is the fact that sponges have a wide range of associated bacteria; and, second, they are a rich source of bioactive substances. Since 1950, a number of bioactive substances with various pharmacological functions have been isolated from marine sponges. However, many of these substances were subsequently shown to be actually synthesized by sponge-associated bacteria. Bacteria associated with marine sponges constitute an interesting source of novel bioactive compounds with biotechnological potential such as antimicrobial substances, enzymes and surfactants. In addition, these bacteria may be biofilm forming and can act as bioindicators in bioremediation processes of environmental pollution caused by oil and heavy metals. This review focuses on the biotechnological applications of these microorganisms.

UI MeSH Term Description Entries
D011161 Porifera The phylum of sponges which are sessile, suspension-feeding, multicellular animals that utilize flagellated cells called choanocytes to circulate water. Most are hermaphroditic. They are probably an early evolutionary side branch that gave rise to no other group of animals. Except for about 150 freshwater species, sponges are marine animals. They are a source of ALKALOIDS; STEROLS; and other complex molecules useful in medicine and biological research. Demospongiae,Sponges (Zoology),Sponge (Zoology),Sponges,Poriferas,Sponge
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D001673 Biodegradation, Environmental Elimination of ENVIRONMENTAL POLLUTANTS; PESTICIDES and other waste using living organisms, usually involving intervention of environmental or sanitation engineers. Bioremediation,Phytoremediation,Natural Attenuation, Pollution,Environmental Biodegradation,Pollution Natural Attenuation
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D001709 Biotechnology Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., GENETIC ENGINEERING) is a central focus; laboratory methods used include TRANSFECTION and CLONING technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction. Biotechnologies

Related Publications

Juliana F Santos-Gandelman, and Marcia Giambiagi-deMarval, and Walter M R Oelemann, and Marinella S Laport
February 2018, Applied and environmental microbiology,
Juliana F Santos-Gandelman, and Marcia Giambiagi-deMarval, and Walter M R Oelemann, and Marinella S Laport
June 2007, Microbiology and molecular biology reviews : MMBR,
Juliana F Santos-Gandelman, and Marcia Giambiagi-deMarval, and Walter M R Oelemann, and Marinella S Laport
January 2022, Frontiers in microbiology,
Juliana F Santos-Gandelman, and Marcia Giambiagi-deMarval, and Walter M R Oelemann, and Marinella S Laport
July 2006, Journal of industrial microbiology & biotechnology,
Juliana F Santos-Gandelman, and Marcia Giambiagi-deMarval, and Walter M R Oelemann, and Marinella S Laport
January 2005, Marine biotechnology (New York, N.Y.),
Juliana F Santos-Gandelman, and Marcia Giambiagi-deMarval, and Walter M R Oelemann, and Marinella S Laport
January 2014, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology],
Juliana F Santos-Gandelman, and Marcia Giambiagi-deMarval, and Walter M R Oelemann, and Marinella S Laport
May 2017, Critical reviews in microbiology,
Juliana F Santos-Gandelman, and Marcia Giambiagi-deMarval, and Walter M R Oelemann, and Marinella S Laport
October 2021, Microorganisms,
Juliana F Santos-Gandelman, and Marcia Giambiagi-deMarval, and Walter M R Oelemann, and Marinella S Laport
January 2011, Biotechnology advances,
Juliana F Santos-Gandelman, and Marcia Giambiagi-deMarval, and Walter M R Oelemann, and Marinella S Laport
April 2016, Current opinion in chemical biology,
Copied contents to your clipboard!